Stanley Laman Group, Ltd. Bluebird Bio, Inc. Transaction History

Stanley Laman Group, Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 08, 2019	SELL	$59.47 - $93.1 $113,706 - $178,007	-1,912 Closed	0 $0
Q2 2019 Aug 01, 2019	BUY	$75.84 - $105.21 $145,006 - $201,161	1,912 New	1,912 $243,000
Q1 2019 May 10, 2019	SELL	$64.44 - $104.11 $130,297 - $210,510	-2,022 Closed	0 $0
Q4 2018 Feb 07, 2019	BUY	$59.1 - $93.26 $119,500 - $188,571	2,022 New	2,022 $201,000
Q3 2018 Oct 30, 2018	SELL	$88.86 - $117.49 $388,140 - $513,196	-4,368 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$99.64 - $127.59 $435,227 - $557,313	4,368 New	4,368 $686,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Stanley Laman Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stanley Laman Group, Ltd. with notifications on news.